Side-by-side comparison of AI visibility scores, market position, and capabilities
Los Angeles textile-to-textile molecular recycler; cycora® regenerated polyester with Inditex €70M+ supply deal and Goldwin FW2025 partnership; $44M raised with 250,000 T-shirt/day facility by 2026 competing with Evrnu for circular fashion materials.
Ambercycle is a Los Angeles, California-based materials science company — backed with approximately $44 million in total funding including investments from Goldwin Play Earth Fund, Shinkong Synthetic Fibers, and others — providing the global apparel and textile industry with cycora®, the world's first commercial-scale textile-to-textile regenerated polyester produced through the company's proprietary Ambercycling™ molecular regeneration technology that transforms post-consumer textile waste into virgin-grade polyester fiber. Key brand partnerships include Inditex/Zara (€70+ million three-year supply agreement), Athleta, REI, Reformation, and GANNI, with manufacturing through MAS Holdings. Ambercycle plans to open a commercial-scale facility capable of processing the equivalent of 250,000 T-shirts per day by 2026. cycora® won Time Magazine's Best Inventions of 2024 recognition. Founded 2015 by UC Davis alumni Shay Sethi (CEO) and Moby Ahmed.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.